seed
Stage
About
Sola Bio develops gene therapies using its proprietary JUMP70 platform to treat neurodegenerative and conformational diseases by restoring the body's natural protein-folding machinery to eliminate misfolded proteins.
Explore Sola Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.